Recent News

• 08.25.2025 - Patrick Trucchio
• 08.25.2025 - Patrick Trucchio
• 08.08.2025 - Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
• 08.08.2025 - Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
• 08.08.2025 - Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
• 08.08.2025 - Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes
• 08.08.2025 - Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes
• 08.08.2025 - Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes

Recent Filings

• 08.18.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.18.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.12.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.11.2025 - 8-K Current report
• 08.11.2025 - 424B5 Prospectus [Rule 424(b)(5)]